Volume 167, No. 222 covering the 1st Session of the 117th Congress (2021 - 2022) was published by the Congressional Record.
The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
“EXECUTIVE COMMUNICATIONS, ETC.” mentioning the Environmental Protection Agency was published in the in the House of Representatives section section on page H7846 on Dec. 30, 2021.
More than half of the Agency's employees are engineers, scientists and protection specialists. The Climate Reality Project, a global climate activist organization, accused Agency leadership in the last five years of undermining its main mission.
The publication is reproduced in full below:
EXECUTIVE COMMUNICATIONS, ETC.
Under clause 2 of rule XIV, executive communications were taken from the Speaker's table and referred as follows:
EC-3031. A letter from the Associate Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Pyflubumide; Pesticide Tolerances [EPA-HQ-OPP-2020-0421; FRL-9282-01-OCSPP] received December 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-3032. A letter from the Associate Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final action -- Findings of Failure to Submit State Implementation Plan Revisions for the 2016 Oil and Natural Gas Industry Control Techniques Guidelines for the 2015 Ozone National Ambient Air Quality Standards
(NAAQS) and for States in the Ozone Transport Region [EPA-HQ-OAR-2021-0868; FRL-9251-01-OAR] received December 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-3033. A letter from the Associate Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- MCPA; Pesticide Tolerances [EPA-HQ-OPP-2020-0691; FRL-9273-01-OCSPP] received December 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-3034. A letter from the Associate Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- a-Terpineol (CAS No. 98-55-5); Tolerance Exemptions [EPA-HQ-OPP-2021-0659; FRL-9322-01-OCSPP] received December 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-3035. A letter from the Associate Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Mefentrifluconazole; Pesticide Tolerances [EPA-HQ-OPP-2020-0538; FRL-9194-01-OSCPP] received December 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-3036. A letter from the Director, Office of Acquisition Policy, Office of Government-wide Policy, General Services Administration, transmitting the Administration's summary presentation of final rules -- Federal Acquisition Regulation; Federal Acquisition Circular 2022-02; Introduction [Docket No.: FAR-2021-0051, Sequence No. 6] received December 20, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Oversight and Reform.
EC-3037. A letter from the Director, Office of Acquisition Policy, Office of Government-wide Policy, General Services Administration, transmitting the Administration's final rule
-- Federal Acquisition Regulation; Technical Amendments [FAC 2022-02; Item II; Docket No.: FAR-2021-0052; Sequence No. 4] received December 20, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Oversight and Reform.
EC-3038. A letter from the Director, Office of Acquisition Policy, Office of Government-wide Policy, General Services Administration, transmitting the Administration's final rule
-- Federal Acquisition Regulation: Update to Certain Online References in the FAR [FAC 2022-02; FAR Case 2021-003; Item I; Docket No.: FAR-2021-0003; Sequence No. 1] (RIN: 9000-AO21) received December 20, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Oversight and Reform.
EC-3039. A letter from the Director, Office of Acquisition Policy, Office of Government-wide Policy, General Services Administration, transmitting the Administration's small entity compliance guide -- Federal Acquisition Regulation; Federal Acquisition Circular 2022-02; Small Entity Compliance Guide [Docket No.: FAR-2021-0051, Sequence No. 6] received December 20, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Oversight and Reform.
EC-3040. A letter from the Regulations Coordinator, Centers for Medicare and Medicaid Services, Department of Health and Human Services, transmitting the Department's final rule -- Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Price Transparency of Hospital Standard Charges; Radiation Oncology Model [CMS-1753-FC] (RIN: 0938-AU43) received December 9, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); jointly to the Committees on Energy and Commerce and Ways and Means.
____________________
Alerts Sign-up